Obesity in relation to morbidity and mortality in COVID-19
Keywords:
obesity, morbidity, mortality, COVID-19.Abstract
Introduction: Obesity and COVID-19 are global pandemics that constitute a major health problem at present, raising mortality rates and affecting all population groups, especially the most vulnerable, demonstrating that there is no sufficiently well prepared health system that can counteract the effects of their coexistence.
Objective: To investigate the relationship between obesity and morbidity and mortality in patients with COVID-19.
Material and Methods: A total of 47 sources were reviewed in the PubMed, Lilacs, SciELO and Cumed databases, of which 28 citations in ENGLISH and SPANISH versions were used. The search terms “obesity and COVID-19”, “Mortality”, “Morbidity and COVID-19”, “obesity and SARS-CoV-2” were also used.
Development: Current scientific evidence shows that the events related to the COVID-19 disease are worse in people with obesity and that it affects most physiological processes and system functions, leading to a worsening of patients with SARS-CoV-2 coronavirus.
Conclusions: Obesity is a risk factor for mortality in patients with COVID-19. Associated comorbidities, insulin resistance, hypercoagulability and prothrombotic state, limitations of respiratory functions and vitamin D deficiency, among others, are factors that lead to worse evolution and mortality.
Downloads
References
1. Suárez Carmona W, Sánchez Oliver AJ, González Jurado JA. Fisiopatología de la obesidad: perspectiva actual. Rev Chil Nutr [Internet]. 2017 Jul [Citado 20/03/2022];44(3):[Aprox. 8 p.]. Disponible en: http://dx.doi.org/10.4067/S0717-75182017000300226
2. Rogge MM, Gautam B. Biology of obesity and weight regain: Implications for clinical practice. J Am Assoc Nurse Pract [Internet]. 2017 [Citado 20/03/2022];29(S1):[Aprox. 14 p.]. Disponible en: http://doi:10.1002/2327-6924.12504
3. World Obesity Federation. Obesity: Missing the 2025 Global Targets [Internet]. London: World Obesity Federation; 2020 [Citado 20/03/2022]. Disponible en: www.worldobesity.org
4. Rivas Estany E, de la Noval García R. Obesidad en Cuba y otras regiones del mundo. Consideraciones generales y acciones nacionales de prevención. Anales de la Academia de Ciencias de Cuba [Internet]. 2021 [Citado 20/03/2022];11(1):[Aprox. 8 p.]. Disponible en: http://www.revistaccuba.cu/index.php/revacc/article/view/887.
5. León Álvarez JL, Calderón Martínez M, Gutiérrez Rojas AR. Análisis de mortalidad y comorbilidad por Covid-19 en Cuba. Rev Cuban Med [Internet]. 2021 Jun [Citado 22/03/2022];60(2):[Aprox. 15 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232021000200004
6. Amancio Castro AM, del Carpio Flórez S. Relación entre las comorbilidades y la morbilidad y mortalidad en la COVID-19. Anales de la Academia de Ciencias de Cuba [Internet]. 2021 may-ago [Citado 22/03/2022];11(2): [Aprox. 6 p.]. Disponible en: http://scielo.sld.cu/pdf/aacc/v11n2/2304-0106-aacc-11-02-e936.pdf
7. García Rodríguez V, López Murillo M. COVID 19 y el Síndrome Metabólico: dos pandemias que se cruzan entre la población mexicana. RD-ICUAP [Internet]. 2021[Citado 20/03/2022];7(20):[Aprox. 23 p.]. Disponible en: http://rd.buap.mx/ojs-dm/index.php/rdicuap/article/view/598
8. Kompaniyets L, Goodman AB, Belay B. Body Mass Index and Risk for COVID-19–Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death — United States, March–December 2020. Morb Mortal Wkly Rep [Internet]. 2021 [Citado 22/03/2022];70(10):[Aprox. 6 p.]. Disponible en: http://doi:10.15585/MMWR.MM7010E4
9. Bonilla PS, Romero JJ, Arita IB. COVID-19 una perspectiva desde el punto de vista endocrinológico. Acta pediátr Hondu [Internet]. 2020 Abr-Sep [Citado 24/03/2022];11(1):[Aprox. 6 p.]. Disponible en: http://www.bvs.hn/APH/pdf/APHVol11/pdf/APHVol11-1-2020-6.pdf
10. Denson J, Gillet AS, Zu Y. Metabolic syndrome and acute respiratory distress syndrome in hospitalized patients with COVID-19. JAMA Netw Open [Internet]. 2021 Dec [Citado 25/03/2022];4(12):[Aprox. 6 p.]. Disponible en: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2787394
11. Petrova D, Salamanca Fernández E, Rodríguez Barranco M, Navarro Pérez P, Jiménez Moleón JJ, Sánchez MJ. La obesidad como factor de riesgo en personas con COVID-19: posibles mecanismos e implicaciones. Aten Primaria [Internet]. 2020 Aug-Sep [Citado 26/03/2022];52(7):496-500. Disponible en: http://doi:10.1016/j.aprim.2020.05.003
12. Huang HK, Bukhari K, Chiung Hui Peng C, Hung DP, Shih MCh,Chang RH et al. The J-shaped relationship between body mass index and mortality in patients with COVID-19: A dose-response meta-analysis. Diabetes Obes Metab [Internet]. 2021 Jul [Citado 27/03/2022];23(7):1701-9. Disponible en: https://dompubs.onlinelibrary.wiley.com/doi/full/10.1111/dom.14382?campaign=wolearlyview
13. Herrera Miranda G. La obesidad como factor de riesgo de complicaciones y muerte en pacientes con COVID-19. Univ Méd Pinareña [Internet]. 2022 [Citado 28/03/2022]; Disponible en: http://revgaleno.sld.cu/inde.php/ump/article/view/827
14. Zhou Y, Chi J, Lv W, Wang Y. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab Res Rev [Internet]. 2021 Feb [Citado 28/03/2022];37(2):[Aprox. 6 p.]. Disponible en: https://onlinelibrary.wiley.com/doi/10.1002/dmrr.3377
15. Hussain A, Mahawar K, Xia Z, Yang W, El-Hasani S. Obesity and mortality of COVID-19. Meta-analysis. Obes Res Clin Pract [Internet]. 2020 Jul-Aug [Citado 28/03/2022];14(4):[Aprox. 6 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346803
16. Felsenstein S, Herbert JA, McNamara PS, Hedrich CM. COVID-19: Immunology and treatment options. Clinical Immunology [Internet]. 2020 [Citado 29/03/2022];215:[Aprox. 13 p.]. Disponible en: https://doi.org/10.1016/j.clim.2020.108448
17. Cabrera Rode E, Cubas Dueñas I, Díaz O. COVID-19: Importancia de la resistencia a la insulina en la respuesta de la terapia viral con interferón. Rev Cubana Endocrinol [Internet]. 2020 May-Ago [Citado 29/03/2022];31(2):[Aprox. 13 p.]. Disponible en: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=1561-29532020000200008&Ing=es
18. Rubio Herrera M. Obesidad en tiempos de COVID-19. Un desafío de salud global. Endocrinol Diabetes Nutr [Internet]. 2021 Feb [Citado 29/03/2022];68(2):123-9. Disponible en: https://www.elsevier.es/es-revista-endocrinologia-diabetes-nutricion-13-articulo-obesidad-tiempos-covid-19-un-desafio--S2530016420302123
19. López Reyes R, Oscullo G, Jímenez D, Cano I, García Ortega A. Riesgo trombótico y COVID-19; revisión de la evidencia actual para una mejor aproximación diagnóstica y terapéutica. Arch Bronconeumol [Internet]. 2021 Ene [Citado 29/03/2022];57:55-64. Disponible en https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457904/#!po=53.2051
20. Brajkovich I, Gómez Pérez R, Contreras MA, Marante D. El coronavirus SARS-COV-2 o enfermedad por COVID-19 y Diabetes Mellitus. Rev Venez Endocrinol Metab [Internet]. 2020 [Citado 29/03/2022];18(1):3-16. Disponible en: https://www.redalyc.org/jatsRepo/3755/375564145002/html/index.html
21. Albashir AAD. The potential impacts of obesity on COVID-19. Clin Med (Lond) [Internet]. 2020 Jul [Citado 29/03/2022];20(4):109-13. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385759/
22. Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH, et al. Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships. Obes Rev [Internet]. 2020 Nov [Citado 29/03/20229];21(11):[Aprox. 15 p.]. Disponible en: https://www.ncib.nlm.nih.gov/pmc/articles/PMC7461480/#!po=0.299401
23. Petrakis D, Margină D, Tsarouhas K, Tekos F, Stan M, Nikitovic D, et al. Obesity a risk factor for increased COVID 19 prevalence, severity and lethality. Mol Med Rep [Internet]. 2020 Jul [Citado 29/03/2022];22(1):9-19. Disponible en: https://www.ncib.nlm.nih.gov/pmc/articles/PMC7248467/
24. Zurita Cruz JN, Pérez Cervantes SA. Vitamina D, obesidad y COVID-19 en pediatría. Rev Me Pediatr [Internet]. 2021 [Citado 29/03/2022];88(4):129-32. Disponible en: https://wwwmediagraphic.com/cgi-bin/new/resumen.cgi?DARTICULO=102776#
25. Daneshkhah A, Agrawal V, Eshein A, Subramanian H, Roy HK, Backman V. The posible role of Vitamin D in suppressing cytokine storm and associated mortality in COVID-19 patients. medRxiv [Internet]. 2020 [Citado 29/03/2022]; 4(8):[Aprox. 2 p.].. Disponible en: https://doi.org/10.1101/2020.04.08.20058578
26. Laird E, Rhodes J, Kenny RA. Vitamin D and inflammation. Potential implications for severity of COVID-19. Ir Med J. [Internet]. 2021 [Citado 29/03/2022];113(5):[Aprox. 7 p.]. Disponible en: https://imj.ie/vitamin-d-and-inflammation-potential-impications-for-severity-of-COVID-19/
27. Hernández Perera JC, Piñeiro Pérez D. Relación de los niveles de Vitamina D con las tasas de letalidad de la COVID-19: Sus fundamentos, evidencias, y recomendaciones que se pueden asumir. Bol C Cimeq [Internet]. 2020 [Citado 29/03/2022];1(13):2-3. Disponible en: https://instituciones.sld.cu/bolcimeq/resena-blibliografica/relacion-de-los-niveles-de-vitamina-d-con-las-tasas-de-letalidad-de-la-covid-19-sus-fundamentos-y-recomendaciones-que-se-pueden-asumir/
28. Aminian A, Bena J, Pantalone KM, Burguera B. Association of obesity with post acute sequelae off COVID-19. Diabetes Obes Metab [Internet]. 2021 Jun [Citado 29/032022];23(9):2183-8. Disponible en: https://doi.org/10.1111/dom.14454
Download PDF
